RecruitingNot ApplicableNCT06138080

Diagnosing Vesicoureteric Reflux in Children by Direct Isotope Cystography and Contrast Enhanced Voiding Ultrasonography


Sponsor

Turku University Hospital

Enrollment

100 participants

Start Date

May 15, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine the applicability of contrast enhanced voiding ultrasonography in diagnosing vesicoureteral reflux (VUR) in pediatric patients compared to direct isotope cystography. The aim of the study is to find a modality allowing the accurate diagnosis of VUR and the classification of the degree of VUR with the least possible harm from the examinations. The investigators recruit 100 under 6 years old patients who have had at least 2 culture positive urinary tract infections. Exluding criteria are abnormal bladder function and posterior uretral valves. The investigators perform direct isotope cystography and contrast enhanced voiding urosonography during the same day to diagnose and grade VUR. The investigators use standardized volume and speed of bladder filling. The examinations are done by a radiologist and an isotope specialist and they are blinded to the result of the other examination.


Eligibility

Min Age: 0 YearsMax Age: 6 Years

Inclusion Criteria1

  • under 6 years old patients who have had at least 2 culture positive urinary tract infections

Exclusion Criteria2

  • abnormal bladder function
  • posterior uretral valves

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTContrast-enhanced voiding ultrasonography (CEVUS), Direct isotope cystography

We have no specific intervention. We investigate different diagnostic modalities of VUR.


Locations(1)

Turku University hospital

Turku, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06138080